U.S. Transportation Stock News

NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen (BIIB) Stock Looks Near Fair Value After A 57% Run

Biogen stock has delivered a strong 57.5% return over the past year, yet the broader valuation checks suggest the shares now look closer to fairly priced than clearly cheap. Over the last 12 months, Biogen has returned 57.5%, which puts more pressure on today’s buyers to justify the higher entry point with future execution. Progress on newer therapies for Alzheimer’s disease and other conditions can support expectations for future cash flows. However, setbacks in clinical trials and legal...
NasdaqGS:BSP
NasdaqGS:BSPSoftware

US Stock Market Today S&P 500 Futures Slip As Higher Yields Temper Sentiment

The Morning Bull - US Market Morning Update Thursday, Jul, 2 2026 US stock futures are pointing slightly lower this morning, with E mini S&P 500 contracts down about 0.3% and Nasdaq 100 futures off around 0.6%, as investors weigh firm US bond yields against mixed global growth signals. The US 10 year yield is sitting near 4.46%, which keeps borrowing costs relatively high for households and companies. At the same time, manufacturing scorecards in Europe and Asia mostly sit just above or below...
NasdaqGS:MGEE
NasdaqGS:MGEEElectric Utilities

How MGE Energy’s Removal From Russell Growth Indexes Will Impact MGE Energy (MGEE) Investors

In late June 2026, MGE Energy, Inc. was removed from several Russell growth indices, including the Russell 3000 Growth and Russell 2000 Growth benchmarks. This widespread index exclusion is significant because it can trigger large-scale portfolio rebalancing by index-tracking funds and benchmark-conscious institutional investors. We’ll explore how MGE Energy’s removal from multiple Russell growth benchmarks shapes the company’s investment narrative and investor positioning. Capitalize on...
NYSE:BCC
NYSE:BCCTrade Distributors

USMCA Review Has Investors Searching For High Quality U.S. Manufacturing Stocks

Trade policy headlines are back on center stage, with the U.S. stepping away from a long term USMCA deal in favor of annual reviews and possible renegotiations. That shift could reshape expectations for companies tied to North American supply chains, especially in U.S. domestic manufacturing. Rather than reacting blindly to every tariff rumor, you can focus on stocks with solid business health that may be better placed to handle this kind of policy churn. This article looks at 3 stocks...
NYSE:ARI
NYSE:ARIMortgage REITs

Apollo Commercial Real Estate Finance (ARI) Drops Out Of Key Indexes As Valuation Questions Build

Apollo Commercial Real Estate Finance (ARI) has been dropped from several major equity benchmarks, including the Russell 2000 Growth, S&P Composite 1500, and S&P 600 indices, prompting investors to reassess index driven demand for the stock. See our latest analysis for Apollo Commercial Real Estate Finance. Against the index removals backdrop, Apollo Commercial Real Estate Finance’s share price has eased in the short term, with a 1-day share price return of 1.31% down and a 30-day share price...
NYSE:SRFM
NYSE:SRFMAirlines

Surf Air Mobility (SRFM) Deepens Palantir Partnership and Electric Trials in Hawai‘i Is The Moat Emerging?

In late June 2026, Palantir Technologies and Surf Air Mobility expanded their partnership to accelerate the development and commercialization of SurfOS aviation software suites, while Surf Air Mobility also launched an electric aircraft demonstration program in Hawai‘i with BETA Technologies and Hawaiian Airlines to test future regional cargo and passenger operations. Together, these moves position Surf Air Mobility at the intersection of AI-enabled aviation software and low-emission...
NasdaqGS:JACK
NasdaqGS:JACKHospitality

Is Jack In The Box (JACK) A Bargain As Refinancing And Index Moves Lift Shares?

Jack in the Box (JACK) has suddenly moved back onto investor radar after a sharp rally tied to a $500 million debt refinancing, heavy short covering, and fresh inclusions in several Russell equity indices. See our latest analysis for Jack in the Box. At a share price of $17.41, Jack in the Box has seen sharp short term momentum, with a 30 day share price return of 29.15% and a 90 day return of 74.27%. However, the 1 year total shareholder return is down 15.44% and the 5 year total shareholder...
NYSE:FLNG
NYSE:FLNGOil and Gas

Does FLEX LNG’s (FLNG) Index Exit Recast How Investors View Its Long-Term Contract Strategy?

FLEX LNG Ltd. (NYSE: FLNG) was recently removed from the Russell 2000 Dynamic Index, an event that can affect index-linked investor positioning and liquidity. This index exit may shift the shareholder mix toward more active investors, potentially changing how FLEX LNG’s long-term contract story is assessed. Next, we’ll examine how FLEX LNG’s removal from the Russell 2000 Dynamic Index could influence its long-term investment narrative. We've uncovered the 8 dividend fortresses yielding 5%+...
NasdaqGS:ECPG
NasdaqGS:ECPGConsumer Finance

Does Encore Capital Group’s (ECPG) Russell 2000 Defensive Inclusion Redefine Its Consumer Finance Risk Profile?

On 27 June 2026, Encore Capital Group, Inc. was added to both the Russell 2000 Defensive Index and the Russell 2000 Value-Defensive Index, shortly after its CIO presented at the Confidential Computing Summit in San Francisco. These index additions can increase visibility and passive fund interest in Encore, potentially reinforcing its positioning as a more defensively oriented consumer finance name. Next, we’ll examine how Encore’s inclusion in the Russell 2000 defensive indices interacts...
NYSE:SLVM
NYSE:SLVMForestry

Is Sylvamo (SLVM) Undervalued As Russell Index Removal Reshapes Demand?

Sylvamo (SLVM) was removed from several Russell growth benchmarks on 27 June, a technical index change that can influence how index-linked funds and some active managers size their positions in the stock. See our latest analysis for Sylvamo. That index removal comes after a period of softer momentum for Sylvamo, with the share price down 5.95% over the past week and 21.62% year to date. The 3 year total shareholder return is modestly positive at 2.20%, suggesting recent selling pressure is...
NasdaqGM:PSNL
NasdaqGM:PSNLLife Sciences

Is Personalis (PSNL) Fully Valued Following Its Sharp Share Price Run?

Recent Performance Snapshot for Personalis Stock Personalis (PSNL) has drawn fresh attention after a stretch of strong share price performance, with the stock up over the past week, month, past 3 months and year, alongside positive annual revenue and net income growth figures. At a last close of $13.79, Personalis carries a market value of about $1.4b, supported by reported revenue of $64.515 million and a net loss of $95.552 million, which keeps profitability in focus for investors. See our...
NasdaqCM:UNCY
NasdaqCM:UNCYBiotechs

Unicycive Therapeutics (UNCY) On FDA Setback Still Carries A Fair Value Debate

Unicycive Therapeutics (UNCY) is back in focus after the US Food and Drug Administration issued a Complete Response Letter on its resubmitted New Drug Application for oxylanthanum carbonate, keeping approval on hold over third party manufacturing issues. See our latest analysis for Unicycive Therapeutics. The FDA letter and the recent expansion of Unicycive Therapeutics' at-the-market program have coincided with sharp share price swings, including a 12.58% 1-day share price return, but 7-day...
NasdaqGS:CNOB
NasdaqGS:CNOBBanks

3 US Regional Bank Stocks for Higher Rates and Tougher Deposit Competition

Rising rate expectations, persistent inflation pressures, and a less predictable Federal Reserve are reshaping how investors think about US regional banks. With markets now entertaining the idea of rate hikes instead of cuts, the way these banks price loans, manage deposits, and handle funding costs is back in focus. This article walks through three regional bank stocks from our US Regional Banks screener that are closely tied to the current policy debate and economic backdrop. By the end,...
NasdaqGS:CRNX
NasdaqGS:CRNXPharmaceuticals

Crinetics Pharmaceuticals (CRNX) Is Up 6.9% After Promising Phase 2 Atumelnant And Paltusotine Data Release - Has The Bull Case Changed?

Crinetics Pharmaceuticals recently presented Phase 2 TouCAHn data showing atumelnant reduced glucocorticoid doses while maintaining androgen control in classic congenital adrenal hyperplasia, and shared two-year PALSONIFY (paltusotine) data in acromegaly indicating maintained disease control and tolerability, while also scheduling its second-quarter 2026 earnings release and business update call for August 4, 2026. Together, these clinical updates highlight Crinetics’ progress in rare...
NasdaqGS:LQDT
NasdaqGS:LQDTCommercial Services

Supply Chain Stocks Facing A Pricing Power Test

Supply chain disruptions are doing more than keeping shelves patchy; they are reshaping pricing power across logistics, shipping, ports, and storage. When goods are harder to replace, companies that move and manage them can sometimes set terms instead of just accepting them, while weaker operators risk being squeezed by higher costs and lost volumes. This article looks at three stocks from a Supply Chain Infrastructure and Logistics Companies screener that are closely tied to these pressures...
NasdaqGS:ASTE
NasdaqGS:ASTEMachinery

CUSMA Uncertainty Makes These 3 U.S. Manufacturing Stocks Worth A Closer Look

Trade friction between the U.S., Canada and Mexico is back in focus as the future of CUSMA turns uncertain, and that has direct implications for stocks tied to cross border supply chains. While many manufacturers rely heavily on tariff friendly trade, some U.S. domestic producers have business models that may be less exposed to potential changes in the agreement. This article looks at how that news backdrop might matter for your portfolio and highlights 3 U.S. domestic manufacturing stocks...
NYSE:ABX
NYSE:ABXInsurance

Abacus Global Management (ABX) Could Be 6% Overvalued As Legal Win Lifts Shares

Abacus Global Management (ABX) drew investor attention after its stock gained 7.3% in the latest session, following a federal court decision that denied Coventry First's motion to dismiss Abacus's defamation lawsuit. See our latest analysis for Abacus Global Management. That legal win slots into a strong recent run for Abacus Global Management, with a 30 day share price return of 29.06% and a 1 year total shareholder return of 125.86%, suggesting momentum has been building for some time. If...
NasdaqGS:PRVA
NasdaqGS:PRVAHealthcare

3 Quality Stocks Built For A Pricey Market

With valuations stretched on popular benchmarks and volatility picking up, many investors are asking whether their portfolios are built on hype or on substance. Elevated measures such as the Shiller CAPE Ratio and the Buffett indicator point to a market where quality and resilience matter more than ever. This article looks at three stocks from our Quality Stocks screener that are closely exposed to the current market backdrop, focusing on balance sheet strength, earnings consistency, and risk...
NYSE:ASB
NYSE:ASBBanks

Higher For Longer Rates Could Lift These US Bank Stocks

With the Federal Reserve signaling a tougher stance on inflation and markets weighing the risk of higher-for-longer interest rates, large US bank stocks are back in focus. Higher borrowing costs can reshape lending margins, credit demand, and investor expectations in different ways. This article looks at 3 US large cap bank stocks from our screener that are closely tied to the latest Fed commentary and inflation data. It aims to help you think through where the current macro backdrop might...
NYSE:DBD
NYSE:DBDTech

Should Diebold Nixdorf’s (DBD) Shift Into Defensive Russell Indices Require Action From Investors?

On 27 June 2026, Diebold Nixdorf, Incorporated was removed from several Russell value-oriented benchmarks but added to the Russell 2000 Defensive and Russell 2000 Growth-Defensive indices, reflecting a reclassification of the stock’s style and risk profile. This broad reshuffling across multiple Russell indices can alter how index-tracking funds and style-focused investors engage with Diebold Nixdorf, potentially reshaping its shareholder base and trading characteristics. We’ll now examine...
NasdaqGS:AEVA
NasdaqGS:AEVAElectronic

Aeva Technologies (AEVA) Is Up 38.7% After Peer’s BABA-Compliant Lidar Win Highlights Physical AI Potential

In late June 2026, Ouster’s Rev8 lidar achieved BABA Act compliance, unlocking eligibility for US federally funded infrastructure projects and fueling renewed interest in physical AI lidar applications across the sector. This regulatory milestone for a peer has shone a spotlight on Aeva Technologies’ 4D lidar platform and broader lidar sensing ecosystem, underscoring how industry-wide policy wins can enhance perceived opportunities for adjacent players without any new company-specific...
NYSE:GWW
NYSE:GWWTrade Distributors

Grainger (GWW) Stock Gets A New Growth Angle As Digital Sales Take The Lead

W.W. Grainger (NYSE:GWW) reports that digital channels now generate the majority of its North American sales. Management highlights continued progress in the company’s e commerce and digital transformation efforts. Recent guidance points to a sustained growth outlook supported by higher digital adoption and operational confidence. W.W. Grainger enters this new digital phase with a share price of $1,338.24 and a long track record in industrial distribution. The stock is up 33.3% year to date...
NYSE:VTEX
NYSE:VTEXIT

3 Software Stocks Retail Investors Are Watching As Rate Cut Hopes Lift Growth

The Federal Reserve’s hint at a possible pause in rate hikes, alongside moderating inflation and solid job growth, has put growth stocks back in focus for many investors watching how future data might shift policy again. Technology companies in particular can be sensitive to interest rate expectations, credit conditions and economic confidence, which makes this news event especially relevant. This article looks at 3 growth stocks from our technology sector screener that appear positively...